Anika Therapeutics Inc.
15.59
-0.33 (-2.07%)
At close: Jan 14, 2025, 3:59 PM
15.58
-0.06%
After-hours Jan 14, 2025, 04:00 PM EST
undefined%
Bid 12.9
Market Cap 228.32M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -6.64
PE Ratio (ttm) -2.35
Forward PE n/a
Analyst Buy
Ask 16.54
Volume 37,396
Avg. Volume (20D) 101,691
Open 15.85
Previous Close 15.92
Day's Range 15.49 - 15.89
52-Week Range 15.40 - 29.12
Beta undefined

About ANIK

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain manageme...

Sector Healthcare
IPO Date May 3, 1993
Employees 357
Stock Exchange NASDAQ
Ticker Symbol ANIK

Analyst Forecast

According to 2 analyst ratings, the average rating for ANIK stock is "Buy." The 12-month stock price forecast is $24.5, which is an increase of 57.15% from the latest price.

Buy 50.00%
Hold 50.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Anika Therapeutics Inc. is scheduled to release its earnings on Mar 12, 2025, during market hours.
Analysts project revenue of $29.00M, reflecting a -32.51% YoY shrinking and earnings per share of 0.09, making a 80.00% increase YoY.
2 months ago · Source
-30.67%
Anika Therapeutics shares are trading lower after ... Unlock content with Pro Subscription